Company intelligence / Profile preview

NaZura BioHealth

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Developing Lovidia, a dietary supplement for weight management. Prototype showed 3x more subjects losing 5% body weight vs placebo in 16-week study; optimized version planned for Q2 2014 launch. 16-week study with optimized product fully enrolled, results expected Q4 2013.[1]

Therapeutic areas: Endocrinology
Modalities: Dietary supplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on NaZura BioHealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NaZura BioHealth.

Explore the full profile